HIPP RAYMOND R 4
4 · NEOGENOMICS INC · Filed Aug 27, 2019
Insider Transaction Report
Form 4
HIPP RAYMOND R
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2019-08-23−2,777→ 0 totalExercise: $9.11From: 2017-07-28Exp: 2021-07-28→ Common Stock (2,777 underlying) - Exercise/Conversion
Common Stock
2019-08-23$11.60/sh+3,017$34,997→ 144,016 total - Exercise/Conversion
Common Stock
2019-08-23$7.27/sh+3,333$24,231→ 147,349 total - Exercise/Conversion
Common Stock
2019-08-23$9.11/sh+2,777$25,298→ 150,126 total - Sale
Common Stock
2019-08-26$24.79/sh−15,424$382,361→ 134,102 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-08-23−3,333→ 3,334 totalExercise: $7.27From: 2018-05-25Exp: 2022-05-25→ Common Stock (6,667 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2019-08-23−3,017→ 0 totalExercise: $11.60From: 2019-06-01Exp: 2023-06-01→ Common Stock (3,017 underlying) - Sale
Common Stock
2019-08-23$25.02/sh−600$15,012→ 149,526 total
Holdings
- 4,269
Stock Option (Right to Buy)
Exercise: $22.52From: 2020-06-06Exp: 2026-06-06→ Common Stock (4,269 underlying)
Footnotes (2)
- [F1]On July 28, 2016, Mr. Hipp was granted 8,333 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- [F2]On May 25, 2017, Mr. Hipp was granted 10,000 stock options. The options vest ratably on the next three anniversary dates of the grant date.